Impact of patient's specification on clinical outcome for an I-131 ablation therapy with differentiated thyroid carcinoma.

被引：0

作者：

Nakayama, M. ^{[1
]}

Okizaki, A. ^{[1
]}

Sakaguchi, M. ^{[2
]}

Uno, T. ^{[2
]}

Sato, J. ^{[2
]}

Ishitoya, S. ^{[1
]}

机构：

[1] Asahikawa Med Univ, Dept Radiol, Asahikawa, Hokkaido, Japan

[2] Asahikawa Med Univ Hosp, Radiol Technol Sect, Asahikawa, Hokkaido, Japan

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：S353 / S353

页数：1

共 50 条

[1] HOW SAFE FOR THE PATIENT IS I-131 THERAPY FOR DIFFERENTIATED THYROID-CARCINOMA
HAYNIE, TP
VASSILOPOULOUSELLIN, R
JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (01) : 27 - 28
[2] Pulmonary I-131 Radioiodine Clearance in Patients with Differentiated Thyroid Carcinoma.
Selkinski, I.
Happel, C.
Middendorp, M.
Plastowez, W.
Sauter, B.
Kranert, T.
Gruenwald, F.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S427 - S427
[3] EFFECTS OF I-131 ABLATION OF THYROID REMNANTS AND I-131-THERAPY OF METASTASES ON SERUM THYROGLOBULIN LEVELS IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
SANGUINETI, M
RANDAZZO, M
CANEVAROLLO, N
BERTOLAZZI, L
ZINO, V
JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1983, 27 (02): : 188 - 189
[4] Impact of post-thyroidectomy I-123 versus I-131 Whole Body Scan on the outcome of radioactive iodine (I-131) ablation for differentiated thyroid carcinoma: A comparative study
Sayed, M. H. M.
Fadl, F. A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S342 - S342
[5] Rate of thyroglossal duct remnant visualization after total thyroidectomy for differentiated thyroid carcinoma and its impact on clinical outcome of radioactive iodine (I-131) ablation
Sayed, Mohamed Hosny Mohamed
Farghaly, Hussein Rabie Saleh
Fadl, Fahd Ahmad
INDIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 30 (02): : 116 - 121
[6] Thyroid remnant ablation of differentiated thyroid carcinoma: a comparison of ablation success with high and low doses of radioiodine (I-131)
Elrasad, S. A. A.
Abdelhafeez, Y.
Husseini, M. A.
Amin, R. A. A.
Elrefaei, S.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S328 - S328
[7] Do scanning doses of I-131 stun thyroid remnants? A comparison of 37 vs 111 MBq before first I-131 ablative therapy in patients with differentiated thyroid carcinoma.
Muratet, JP
Giraud, P
Daver, A
Minier, JF
Larra, F
JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 163 - 163
[8] Diagnostic and post-therapy I-131 whole body scans in patients with well-differentiated thyroid carcinoma.
Ozalp, E
Vural, G
Ercakmak, N
Aslan, S
Turgut, B
JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 235P - 235P
[9] I-131 therapy in differentiated thyroid carcinoma patients with high thyroglobulin levels despite negative diagnostic I-131 scans
Akgun, A.
Yazici, B.
Erdim, O.
Ozcan, Z.
Ozkilic, H.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S330 - S330
[10] The therapeutic responses to I-131 ablation in patients of differentiated thyroid carcinoma complicated with nodular goiter
Chai, H.
Zhang, H.
Yu, Y.
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2022, 46 (04): : 169 - 174

← 1 2 3 4 5 →